142667-06-9 Usage
Uses
Used in Pharmaceutical Industry:
2-(5-(methoxycarbonyl)thiophen-2-yl)acetic acid is used as a key intermediate for the synthesis of various drugs and pharmaceuticals, leveraging its structural properties to contribute to the development of new medicinal agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-(5-(methoxycarbonyl)thiophen-2-yl)acetic acid is utilized as a building block for the creation of compounds with potential biological activities, including anti-inflammatory and anti-cancer properties.
Used in Drug Discovery:
2-(5-(methoxycarbonyl)thiophen-2-yl)acetic acid is employed as a crucial component in drug discovery processes, where its unique structure and properties are harnessed to identify and develop new therapeutic agents with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 142667-06-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,6,6 and 7 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 142667-06:
(8*1)+(7*4)+(6*2)+(5*6)+(4*6)+(3*7)+(2*0)+(1*6)=129
129 % 10 = 9
So 142667-06-9 is a valid CAS Registry Number.
142667-06-9Relevant articles and documents
SELECTIVE HDAC6 INHIBITORS
-
Page/Page column 49, (2015/07/15)
The present invention provides hydroxamic acids of the formula described herein, that have activity toward inhibiting histone deacetylases, and in particular HDAC6. Also contemplated are pharmaceutical compositions and methods of use of an effective amount of the hydroxamic acid compounds provided, for treating a disease in a subject. In certain embodiments, the subject is afflicted with cancer, neurodegenerative disease, or HIV infection.
NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS
-
Page/Page column 51, (2011/09/15)
The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
